The Wnt/β-Catenin Pathway Attenuates Experimental Allergic Airway Disease
Sebastian Reuter(Ruhrlandklinik), Christian Taube(Ruhrlandklinik), A Heinz(Johannes Gutenberg University Mainz), Svetlana Ohngemach(Johannes Gutenberg University Mainz), Roland Buhl(Johannes Gutenberg University Mainz), Matthias Bros(Johannes Gutenberg University Mainz), Leonid Eshkind(Johannes Gutenberg University Mainz), Michael Stassen(Johannes Gutenberg University Mainz), Uğur Şahin(Johannes Gutenberg University Mainz), Evelyn Montermann(Johannes Gutenberg University Mainz), H Beckert(Johannes Gutenberg University Mainz), Helen Martin(Mersey Care NHS Trust), Christina Belz(Johannes Gutenberg University Mainz)
Cited by 49
Related Papers
mRNA-based therapeutics — developing a new class of drugs
|Nature Reviews Drug Discovery|2014|2.4k
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
|Nature|2021|828
BNT162b vaccines protect rhesus macaques from SARS-CoV-2
|Nature|2021|735